Relafen DS Interactions
There are 405 drugs known to interact with Relafen DS (nabumetone), along with 11 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 97 are major, 300 are moderate, and 8 are minor.
- View all 405 medications that may interact with Relafen DS
- View Relafen DS alcohol/food interactions (3)
- View Relafen DS disease interactions (11)
Most frequently checked interactions
View interaction reports for Relafen DS (nabumetone) and the medicines listed below.
- acetaminophen / hydrocodone
- atorvastatin
- baclofen
- Botox (onabotulinumtoxinA)
- clonazepam
- cyanocobalamin
- cyclobenzaprine
- dextroamphetamine
- estradiol
- etodolac
- ferrous sulfate
- folic acid
- golimumab
- hydroxyzine
- losartan
- methocarbamol
- methotrexate
- omeprazole
- progesterone
- sertraline
- sulfasalazine
- temazepam
- tizanidine
- trazodone
- Unithroid (levothyroxine)
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- zolpidem
Relafen DS alcohol/food interactions
There are 3 alcohol/food interactions with Relafen DS (nabumetone).
Relafen DS disease interactions
There are 11 disease interactions with Relafen DS (nabumetone) which include:
- asthma
- fluid retention
- GI toxicity
- rash
- renal toxicities
- thrombosis
- liver disease
- anemia
- hepatotoxicity
- hyperkalemia
- platelet aggregation inhibition
Report options
QR code containing a link to this page
More about Relafen DS (nabumetone)
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.